Welcome to the solid-state analysis webinar hub
Solid-state analysis is the cornerstone of successful drug development, providing critical insights into the physical and chemical properties of Active Pharmaceutical Ingredients (APIs).
By focusing on key parameters such as particle size, particle shape, polymorphism, and elemental composition, we can enhance bioavailability and ensure the consistency and efficacy of drug products.
Explore our webinars, where you’ll find insights, tips and advice from our technology and application experts.
API scale-up strategies
Dive into our API Scale-up Strategies webinar series where our experts help you explore the tools and techniques you need to harness particle size, particle shape, polymorphism, and elemental composition to develop and optimize your processes during the scale-up of drug substances.
API Scale-up Strategies: Accelerate scale up with particle size and shape analysis
API Scale-up Strategies: Crystallization Command
API Scale-up Strategies: Eliminating Impurities
Elemental analysis
Elemental analysis provides detailed information about the elemental composition of APIs, ensuring: purity compliance, safety assurance, and consistency across batches.
Discover how X-ray fluorescence (XRF) and automated imaging can help improve your workflows and deliver better results, faster.
API Scale-up Strategies: Eliminating Impurities
Pharmaceutical Masterclass: Applying the Guidance in USP232 USP233 and ICH Q3D for Elemental Analysis
Reduce the cost of elemental analysis
Controlling polymorphism and crystallization
Polymorphism refers to the existence of an API in multiple crystalline forms, each with distinct physical and chemical properties. Proper management of polymorphism is crucial to ensure stability, optimize solubility, and streamline development.
Why is solid form analysis essential for API development?
Solid form analysis: Get up close and personal with your API
Solid form analysis: Quick and accurate candidate selection
API Scale-up Strategies: Crystallization Command
Particle size and shape analysis
The size and shape of API particles directly influence their dissolution rate, stability, and manufacturability. Precise control over these parameters can lead to: improved dissolution rates, enhanced processability (i.e. improved flow properties), and better consistency in product performance and therapeutic outcomes.
Why pharmaceutical scientists should stop worrying about the accuracy of particle size analysis
First steps in automated image analysis
API Scale-up Strategies: Accelerate scale up with particle size and shape analysis
Focus on Pharma
Need to optimize your development processes, while improving product safety at a lower cost?
This webinar series is aimed at helping pharmaceutical customers improve and simplify their selection of analytical methods for materials characterization.